Synlogic (NASDAQ:SYBX) Shares Pass Below 50-Day Moving Average – Here’s What Happened

Synlogic, Inc. (NASDAQ:SYBX)’s stock price passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.47 and traded as low as $1.41. Synlogic shares last traded at $1.43, with a volume of 6,220 shares traded.

Synlogic Stock Performance

The company’s 50-day moving average is $1.47 and its 200 day moving average is $1.59. The company has a market capitalization of $16.74 million, a PE ratio of -0.14 and a beta of 0.84.

Synlogic (NASDAQ:SYBX) last announced its quarterly earnings data on Thursday, August 8th. The biotechnology company reported $0.16 EPS for the quarter, beating the consensus estimate of ($0.51) by $0.67. Synlogic had a negative net margin of 2,284.65% and a negative return on equity of 194.73%. On average, analysts forecast that Synlogic, Inc. will post -1.98 EPS for the current fiscal year.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.